eSight 1.jpgeSight is a breakthrough wearable device that enhances the functional vision of those living with low vision or legal blindness. eSight helps users be mobile and independent as they engage in virtually all Activities of Daily Living (ADLs). eSight requires no surgery, is registered with the FDA and EUDAMED and is inspected by Health Canada.

eSight significantly improves a person’s remaining retinal function, and has the potential to have a life-changing impact for those with low vision. eSight can help users see the faces of loved ones, travel independently, work for a living and study to their fullest potential.

Users of eSight have ranged in age from 4 to 101, with the device working for individuals living with a variety of conditions and coming from all walks of life. The device is customizable with prescriptions built into the unit.

“The effect this technology can have on the lives of people with vision loss is remarkable,” said John Rafferty, President and CEO of CNIB. “It’s an exciting device that can enable some people to recapture activities they haven’t experienced in decades, like watching their kids play soccer or reading the Sunday morning newspaper.”

CNIB has partnered with eSight to help our eligible clients make the most of the technology available to them. If you have a friend or loved one that you think could benefit from eSight, refer them and give back to CNIB! For every referral that ends up purchasing the device, a portion of the sale will go to support CNIB’s services.

CNIB is proud to support technology which can have such a profound effect on the quality of life of our clients. For more information and to sign up for a demonstration near you, visit


How does eSight work?

A high-speed, high resolution camera in the middle of the eSight electronic glasses captures what a user is looking at in real time.
eSight’s powerful computer instantly processes the Ultra HD video and displays it on two OLED screens in front of the user’s eyes using cutting edge optics.

eSight’s proprietary algorithms enhance the video feed.

Full color video images can be clearly seen by the eSight user with unprecedented visual clarity and no perceptible latency or delay.

With eSight’s patented Bioptic Tilt capability, users can adjust the eyewear to the precise position that, for them, presents the best view of the video while maximizing outer peripheral vision (which is often still functional for people with low vision). This, along with imperceptible short latency, ensures that a user’s balance is not disturbed and, hence, no nausea occurs – common problems with immersive technologies such as virtual reality headsets. Perhaps more importantly, it is the Bioptic Tilt that allows eSight users to be mobile while using the device.

eSight users can easily control color, contrast, focus, brightness and magnification (24X) using a sleek controller and intuitive user interface.

eSight users can take photos, and stream video and games utilizing eSight’s Wi-Fi, Bluetooth and HDMI capabilities.

Who can benefit from eSight eyewear?

eSight has helped improve the functional vision of those living with a variety of eye conditions, including macular degeneration, Stargardt disease, ocular albinism, diabetic retinopathy, Leber’s optic neuropathy, cone-rod dystrophy and other low vision conditions.

What can a person do with their eSight?

What an eSight user does with their restored vision is completely up to them! Aside from operating a motor vehicle, this extends to virtually all independent Activities Daily Living (ADLs), including:

  • Seeing the faces of loved ones, in some cases for the first time
  • Working in an office or a factory
  • Going to school or university
  • Using a computer or smartphone
  • Watching TV
  • Reading
  • Travelling independently
  • Viewing sporting and cultural events
  • Arts and crafts
  • Cooking
  • Walking
  • Playing sports
  • Resuming previously abandoned hobbies (cards, woodworking, etc.)

What clinical evidence exists to prove that eSight really works?

As defined by the FDA and Health Canada, eSight is a Class I medical device. It provides enhanced vision without requiring surgery, pharmaceuticals or other invasive means.
A past study overseen by the CNIB demonstrated that eSight offers a statistically significant improvement in visual acuity and contrast sensitivity for users.
This past year, eSight was the subject of a major new clinical trial that included the participation of many of North America's leading institutions for the study of eye disease, such as:

  • Bascom Palmer Eye Institute at the University of Miami
  • Johns Hopkins University Wilmer Eye Center
  • Kellogg Eye Center at the University of Michigan
  • The Center for Retina and Macular Disease
  • Toronto Western Hospital of University Health Network
  • Université of Montréal

This study, which is now completed, is expected to further validate the ways in which eSight can substantially improve the quality of life and independent Activities of Daily Living (ADLs) for individuals with visual impairment. The data from this trial is expected to be published later in 2017.

Girl wearing eSight playing with LEGO